Showing results (181-190 of 218) with videos related to

Sort By:
Pageof 22
Oncology Reports|January 5, 2007
Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activitiesKoji Yanase, Hitoshi Yoshiji, Yasuhide Ikenaka, et al.
Journal of Gastroenterology|March 26, 2009
Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic ratsHitoshi Yoshiji, Ryuichi Noguchi, Mitsuteru Kitade, et al.
Experimental and Therapeutic Medicine|December 2, 2020
Ascites symptom inventory-7 is a valuable tool for evaluating the effectiveness of tolvaptan in patients with cirrhotic ascitesHideto Kawaratani, Kei Moriya, Tadashi Namisaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 22, 2006
Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis developmentHitoshi Yoshiji, Shigeki Kuriyama, Ryuichi Noguchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesisRyuichi Noguchi, Hitoshi Yoshiji, Shigeki Kuriyama, et al.
International Journal of Molecular Medicine|July 29, 2010
Selective aldosterone blocker ameliorates the progression of non-alcoholic steatohepatitis in ratsRyuichi Noguchi, Hitoshi Yoshiji, Yasuhide Ikenaka, et al.
International Journal of Molecular Medicine|April 6, 2006
Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in ratsHitoshi Yoshiji, Shigeki Kuriyama, Ryuichi Noguchi, et al.
Thrombosis and Haemostasis|June 4, 2008
Comprehensive analysis of ADAMTS13 in patients with liver cirrhosisMasahito Uemura, Yoshihiro Fujimura, Masanori Matsumoto, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in miceHitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii, et al.
Hepatology (Baltimore, Md.)|September 29, 2006
Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in ratsMitsuteru Kitade, Hitoshi Yoshiji, Hideyuki Kojima, et al.
Pageof 22